Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_084f36e3515c0ac02097238c863b9a9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7511bfa639ce8f826e108bf46aa70ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
1992-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb1b9c923540f90a16c3b4e960fe7c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f00385eaf887989acee286a0b603208 |
publicationDate |
1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0614366-B1 |
titleOfInvention |
Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours |
abstract |
A method for treatment of human tumors which are sensitive to the compounds recited below, particularly those which have become resistant to chemotherapy. The method comprises administering an effective amount of creatine phosphate or phosphoenolpyruvic acid. |
priorityDate |
1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |